Substituted imidazopyridazines are potent and selective inhibitors of Plasmodium falciparum calcium-dependent protein kinase 1 (PfCDPK1)
作者:Timothy M. Chapman、Simon A. Osborne、Nathalie Bouloc、Jonathan M. Large、Claire Wallace、Kristian Birchall、Keith H. Ansell、Hayley M. Jones、Debra Taylor、Barbara Clough、Judith L. Green、Anthony A. Holder
DOI:10.1016/j.bmcl.2013.03.017
日期:2013.5
A series of imidazopyridazines which are potent inhibitors of Plasmodium falciparum calcium-dependent protein kinase 1 (PfCDPK1) was identified from a high-throughput screen against the isolated enzyme. Subsequent exploration of the SAR and optimisation has yielded leading members which show promising in vitro anti-parasite activity along with good in vitro ADME and selectivity against human kinases. Initial in vivo testing has revealed good oral bioavailability in a mouse PK study and modest in vivo efficacy in a Plasmodium berghei mouse model of malaria. (C) 2013 Elsevier Ltd. All rights reserved.